Business

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

adminadmin
Nov 26, 2024 - 09:30
 0  0
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Read More

Tags:

Previous Article

Surge of Gang Violence in Haiti Leads U.N. Workers to Flee

Next Article

Trump Plans 25% Tariff on Canada and Mexico, Potentially Crippling Trade

admin
admin

Related Posts

A New Trump Administration Is No Reason to Change Investing Plans

A New Trump Administration Is No Reason to Change Investing...

admin Nov 8, 2024  0  1

Kohl’s Picks C.E.O. of Michaels to Help It Turn Around

Kohl’s Picks C.E.O. of Michaels to Help It Turn Around

admin Nov 26, 2024  0  0

Why There Is Hope for Factory Towns Laid Low by the ‘China Shock’

Why There Is Hope for Factory Towns Laid Low by the ‘China...

admin Nov 1, 2024  0  2